Precision Business Insights

Portfolio

Research Reports

SELECT LICENSE TYPE
Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner

Why Precision Business Insights?

  • Pre and Post Sale Support

    Get in touch with our industry experts to resolve your research queries before and after buying the report. Avail free 60 minutes analyst tele-call to get additional market information before and after purchase

  • Special Pricing and Discounts

    Avail special pricing for the purchase of report sections,regional insights, and historical data. Discounts for government bodies, research institutes, universities, NGO’s and start-up’s

  • In-depth Market Analysis

    Our research reports provides holistic market information with 360 degree analysis. We adopt 3 pronged strategy to analyze the market i.e. Secondary research , primary research, and expert validation

  • Accurate and Reliable Market Data

    Utmost focus on delivering accurate and reliable research reports. We adopt internally developed data mining tools to eliminate any data errors

  • NICHE AND GROWTH MARKETS EXPERTISE

    Proven expertise in delivering new and emerging markets product and technology advancements. We provide market information across the developed and emerging markets

  • ADHERING TO QUICK DELIVERY TIME LINES

    We provide impeccable research reports in quick turnaround time

Anxiety Disorders and Depression Treatment Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024


 

Available formats:    

StumbleUponEmail

Global Anxiety Disorders and Depression Treatment Market

 

By Product Type (MAOIs (Monoamine Oxidase inhibitors), Atypical Antipsychotics, Benzodiazepines, Anticonvulsants, Beta-Blockers, SRIs (Selective Serotonin Reuptake Inhibitors), SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors), TeCAs (Tetracyclic Antidepressants), TCAs (Tricyclic Antidepressants), Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Others), and Geography – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global anxiety disorders and depression treatment market was valued at US $ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

 

Market Outline: Anxiety Disorders and Depression Treatment Market

Anxiety is a disorder that differ from normal feelings of nervousness or anxiousness. It involves excessive anxiety. Anxiety is a normal reaction to stress. For a patient with anxiety disorder, the anxiety does not lessen but can get worse over the period of time. As per the American Psychiatric Association, Anxiety disorders are the most common of mental disorders and affect nearly 30 percent of adults at some point in their lives. The feelings can interfere with the daily activities. There are various kind of anxiety disorders such as social anxiety disorder and panic disorder.

 

Market Dynamics: Anxiety Disorders and Depression Treatment Market

Increase in the prevalence of anxiety disorder and depression is majorly driving the growth of the anxiety disorders and depression treatment market. According to the World Health Organization (WHO), in 2017, over 300 million people of all ages globally are suffering from depression, wherein 800,000 people die due to suicide, of which, anxiety disorders and depression are a prime cause. The rising demand for the antidepressants can be attributed to the growth of the market. Growing geriatric population along with mental disorders are adding fuel for the growth of the anxiety disorders and depression treatment market. However, the factors such as patent expiry of the drugs and adoption of the other treatment options such as herbal treatment are expected to hinder the growth of the market. The growing generic drugs are likely to restrain the growth of the anxiety disorders and depression treatment market.

 

Market Scope: Anxiety Disorders and Depression Treatment Market

Anxiety disorders and depression treatment market is segmented based on the product type and distribution channel

Based on the product type, the market is segmented into the following:

  • MAOIs (Monoamine Oxidase inhibitors)
  • Atypical Antipsychotics
  • Benzodiazepines
  • Anticonvulsants
  • Beta-Blockers
  • SRIs (Selective Serotonin Reuptake Inhibitors)
  • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
  • TeCAs (Tetracyclic Antidepressants)
  • TCAs (Tricyclic Antidepressants)
  • Others

Based on the distribution channel, the market is segmented into the following:

  • Hospital Pharmacies
  • Online Pharmacies
  • Others

 

Regional Analysis:  Anxiety Disorders and Depression Treatment Market

Geographically, global anxiety disorders and depression treatment market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America anxiety disorders and depression treatment market is the dominant market when compared with that of the other regional markets. According to the National Alliance on Mental Illness, Anxiety disorders are the most common mental health concern in the United States. An estimated 40 million adults in the United States (18%) have an anxiety disorder. Meanwhile, approximately 8% of children and teenagers experience an anxiety disorder. Most people develop symptoms before age 21. According to the Mental Health America, in 2014, 1 in every 5 adults have a mental health condition and the condition is observed to be worsening at rapid rates in youth. The Asia Pacific anxiety disorders and depression treatment market is expected to show a luxurious growth over the forecasted period.

 

Competition Assessment: Anxiety Disorders and Depression Treatment Market

Some of the players in the global anxiety disorders and depression treatment market include:

  • Eli Lilly and Company (U.S)
  • Lundbeck A/S (Denmark)
  • AstraZeneca (UK)
  • Merck and Company, Inc. (U.S)
  • Johnson and Johnson (U.S)
  • Sanofi-Aventis (France)
  • GlaxoSmithKline plc (UK)
  • Pfizer, Inc. (U.S)

 

Key Features of the Report:

  • The report covers exhaustive regional information, that includes North America (the USA and Canada), Europe (Germany, France, Italy, UK, Spain, Russia, Poland and Rest of Europe), Asia-Pacific (Japan, China, India, Australia & New Zealand, ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others), South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, Argentian, Venezula, and Rest of Latin America), and Middle East and Africa (Gulf Cooperation Council (GCC) Countries, Israel, South Africa, and Rest of Middle East and Africa)
  • The report provides granular level information about the market size, regional market share, historic market (2013-2017) and forecast (2018-2024)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market
  1. Table of Content
  2. Executive Summary
  3. Global Anxiety Disorders and Depression Treatment Market Introduction
    • Global Anxiety Disorders and Depression Treatment Market – Taxonomy
    • Global Anxiety Disorders and Depression Treatment Market –Definitions
      • Product Type
      • Distribution Channel
  1. Global Anxiety Disorders and Depression Treatment Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Anxiety Disorders and Depression Treatment Market Dynamic Factors – Impact Analysis
    • Global Anxiety Disorders and Depression Treatment Market – Competition Landscape
    • Epidemiology
  2. Global Anxiety Disorders and Depression Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024
    • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market OpportunityAnalysis
  3. Global Anxiety Disorders and Depression Treatment Market, By Product Type, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • MAOIs (Monoamine Oxidase inhibitors)
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Atypical Antipsychotics
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Benzodiazepines
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Anticonvulsants
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Beta-Blockers
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • SRIs (Selective Serotonin Reuptake Inhibitors)
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • TeCAs (Tetracyclic Antidepressants)
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • TCAs (Tricyclic Antidepressants)
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Anxiety Disorders and Depression Treatment Market Forecast, By Distribution Channel, 2013 – 2017 and Forecast, 2018 – 2024
    • Hospital Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Online Pharmacies
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Others
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Anxiety Disorders and Depression Treatment Market Forecast, By Region, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Anxiety Disorders and Depression Treatment Market – Opportunity Analysis Index, By Product Type, By Distribution Channel and Region, 2018 – 2024
  2. North America Anxiety Disorders and Depression Treatment MarketAnalysis,2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • MAOIs (Monoamine Oxidase inhibitors)
      • Atypical Antipsychotics
      • Benzodiazepines
      • Anticonvulsants
      • Beta-Blockers
      • SRIs (Selective Serotonin Reuptake Inhibitors)
      • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
      • TeCAs (Tetracyclic Antidepressants)
      • TCAs (Tricyclic Antidepressants)
      • Others
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2016 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • S.
      • Canada
    • North America Anxiety Disorders and Depression Treatment Market – Opportunity Analysis Index, By Product Type, By Distribution Channel and Country, 2018 – 2024
    • North America Anxiety Disorders and Depression Treatment Market Dynamics – Trends
  3. Europe Anxiety Disorders and Depression Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • MAOIs (Monoamine Oxidase inhibitors)
      • Atypical Antipsychotics
      • Benzodiazepines
      • Anticonvulsants
      • Beta-Blockers
      • SRIs (Selective Serotonin Reuptake Inhibitors)
      • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
      • TeCAs (Tetracyclic Antidepressants)
      • TCAs (Tricyclic Antidepressants)
      • Others
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Germany
      • UK
      • France
      • Spain
      • Italy
      • Russia
      • Poland
      • Rest of Europe
    • Europe Anxiety Disorders and Depression Treatment Market – Opportunity Analysis Index, By Product Type, By Distribution Channel, and Country,2018 – 2024
    • Europe Anxiety Disorders and Depression Treatment Market Dynamics – Trends
  4. Asia-Pacific Anxiety Disorders and Depression Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • MAOIs (Monoamine Oxidase inhibitors)
      • Atypical Antipsychotics
      • Benzodiazepines
      • Anticonvulsants
      • Beta-Blockers
      • SRIs (Selective Serotonin Reuptake Inhibitors)
      • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
      • TeCAs (Tetracyclic Antidepressants)
      • TCAs (Tricyclic Antidepressants)
      • Others
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Japan
      • China
      • India
      • ASEAN
      • Australia & New Zealand
      • Rest of Asia-Pacific
    • Asia-Pacific Anxiety Disorders and Depression Treatment Market – Opportunity Analysis Index, By Product Type, By Distribution Channel, and Country,2018 – 2024
    • Asia-Pacific Anxiety Disorders and Depression Treatment Market Dynamics – Trends
  5. Latin America Anxiety Disorders and Depression Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • MAOIs (Monoamine Oxidase inhibitors)
      • Atypical Antipsychotics
      • Benzodiazepines
      • Anticonvulsants
      • Beta-Blockers
      • SRIs (Selective Serotonin Reuptake Inhibitors)
      • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
      • TeCAs (Tetracyclic Antidepressants)
      • TCAs (Tricyclic Antidepressants)
      • Others
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Brazil
      • Mexico
      • Argentina
      • Venezuela
      • Rest of Latin America
    • Latin America Anxiety Disorders and Depression Treatment Market – Opportunity Analysis Index, By Product Type, By Distribution Channel, and Country,2018 – 2024
    • Latin America Anxiety Disorders and Depression Treatment Market Dynamics – Trends
  6. Middle East and Africa Anxiety Disorders and Depression Treatment Market Analysis, 2013 – 2017 and Forecast, 2018 – 2024 (Revenue, USD Mn)
    • Product Type Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn),Y-o-Y Growth (%), and Market Share (%)
      • MAOIs (Monoamine Oxidase inhibitors)
      • Atypical Antipsychotics
      • Benzodiazepines
      • Anticonvulsants
      • Beta-Blockers
      • SRIs (Selective Serotonin Reuptake Inhibitors)
      • SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors)
      • TeCAs (Tetracyclic Antidepressants)
      • TCAs (Tricyclic Antidepressants)
      • Others
    • Distribution Channel Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
      • Hospital Pharmacies
      • Online Pharmacies
      • Others
    • Country Analysis 2013 – 2017 and Forecast 2018 – 2024 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
      • Gulf Cooperation Council (GCC) Countries
      • Israel
      • South Africa
      • Rest of MEA
    • MEA Anxiety Disorders and Depression Treatment Market – Opportunity Analysis Index, By Product Type, By Distribution Channel, and Country,2018 – 2024
    • MEA Anxiety Disorders and Depression Treatment Market Dynamics – Trends
  7. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, Product Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Eli Lilly and Company (U.S)
      • Lundbeck A/S (Denmark)
      • AstraZeneca (UK)
      • Merck and Company, Inc. (U.S)
      • Johnson and Johnson (U.S)
      • Sanofi-Aventis (France)
      • GlaxoSmithKline plc (UK)
      • Pfizer, Inc. (U.S)
  1. Research Methodology
  2. Key Assumptions and Acronyms

 

  1. Disclaimer
  2. The above mentioned segmentation is tentative; it is changed according to client’s requirement, or research feasibility.

A complementary 2hrs free facility through which report buyers can interact with our pool of experienced analysts for any report related queries, clarifications or additional data requirements

 

Avail Discount  Up To 20%

Need more discount on this report?

Call or e-mail us for:

(U.S.) – +1-866-598-1553

Contact SalesTOLL FREE: +1-866-598-1553